OpenURL Connection Search

Select item for more details and to access through your institution.

Prognostic Value of Serum Paraprotein Response Kinetics in Patients With Newly Diagnosed Multiple Myeloma.
Published in:
Clinical Lymphoma, Myeloma & Leukemia, 2022, v. 22, n. 9, p. e844, doi. 10.1016/j.clml.2022.04.024
By:
- Tamariz-Amador, Luis-Esteban;
- Rodríguez-Otero, Paula;
- Jiménez-Ubieto, Ana;
- Rosiñol, Laura;
- Oriol, Albert;
- Ríos, Rafael;
- Sureda, Anna;
- Blanchard, Maria Jesus;
- Hernández, Miguel Teodoro;
- Perianes, Valentin Cabañas;
- Jarque, Isidro;
- Bargay, Juan;
- Gironella, Mercedes;
- Arriba, Felipe De;
- Palomera, Luis;
- Gonzalez-Montes, Yolanda;
- Martí, Josep M.;
- Krsnik, Isabel;
- Arguiñano, José María;
- González, María Esther
Publication type:
Article
Clinical and Sociodemographic Characteristics of Patients With Relapsed and/or Refractory Multiple Myeloma and Their influence on Treatment in the Real-World Setting in Spain: The CharisMMa Study.
Published in:
Clinical Lymphoma, Myeloma & Leukemia, 2022, v. 22, n. 4, p. e241, doi. 10.1016/j.clml.2021.10.001
By:
- Ocio, Enrique M.;
- Montes-Gaisán, Carmen;
- Bustamante, Gabriela;
- Garzón, Sebastián;
- González, Esther;
- Pérez, Ernesto;
- Sirvent, Maialen;
- Arguiñano, José María;
- González, Yolanda;
- Ríos, Rafael;
- Miguel, Dunia de;
- Grande, Marta;
- Fernández, Alonso;
- Naves, Andrea;
- Rosiñol, Laura
Publication type:
Article
Pomalidomide, Cyclophosphamide, and Dexamethasone for the Treatment of Relapsed/Refractory Multiple Myeloma: Real-World Analysis of the Pethema-GEM Experience.
Published in:
2021
By:
- Rodriguez-Otero, Paula;
- Sirvent, Maialen;
- González-Rodríguez, Ana Pilar;
- Lavilla, Esperanza;
- de Coca, Alfonso García;
- Arguiñano, José María;
- Martí, Josep M.;
- Cabañas, Valentin;
- Motlló, Cristina;
- de Cabo, Erik;
- Encinas, Cristina;
- Murillo, Ilda;
- Hernández-Rivas, Jose Ángel;
- Pérez-Persona, Ernesto;
- Casado, Felipe;
- Sampol, Antonia;
- García, Ricarda;
- Blanchard, María Jesús;
- Anguita, Magdalena;
- Lafuente, Ana Paz
Publication type:
journal article
Safety and tolerability of a 90‐minute rapid infusion of Sandoz biosimilar rituximab in B‐cell lymphoproliferative disorders in a real‐world setting.
Published in:
CTS: Clinical & Translational Science, 2023, v. 16, n. 2, p. 305, doi. 10.1111/cts.13450
By:
- Muntañola, Ana;
- Arguiñano‐Pérez, José María;
- Dávila, Julio;
- de Villambrosia, Sonia González;
- Carpio, Cecilia;
- Jiménez‐Ubieto, Ana;
- Salar, Antonio
Publication type:
Article

Found: 4

Prognostic Value of Serum Paraprotein Response Kinetics in Patients With Newly Diagnosed Multiple Myeloma.

Clinical and Sociodemographic Characteristics of Patients With Relapsed and/or Refractory Multiple Myeloma and Their influence on Treatment in the Real-World Setting in Spain: The CharisMMa Study.

Pomalidomide, Cyclophosphamide, and Dexamethasone for the Treatment of Relapsed/Refractory Multiple Myeloma: Real-World Analysis of the Pethema-GEM Experience.

Safety and tolerability of a 90‐minute rapid infusion of Sandoz biosimilar rituximab in B‐cell lymphoproliferative disorders in a real‐world setting.